|
215 Consultation
on triptan POM to P switch starts Consultation has begun on
the reclassification of sumatriptan and zolmitriptan from prescription-only
to pharmacy medicines for acute relief of migraine attacks ...more
215 Volumatic
discontinued but do not switch devices, says CSM chairman The Volumatic spacer device is being discontinued but GlaxoSmithKline will continue to supply the AeroChamber Plus spacer device as a replacement, Gordon Duff, chairman of the Committee on Safety of Medicines, announced this week in a letter to health professionals
...more
215 New guide
to help prison services launched New guidance has been published to help prison services in England and Wales implement a policy whereby patients are responsible for their own medicines
...more
215 Birdsgrove
House forced to close its doors Birdsgrove House, the country mansion housing the Royal Pharmaceutical Society's rest and recuperation service and addiction treatment centre, is to close with immediate effect
...more
216 European
guideline on paediatric pharmacovigilance drafted Pharmacovigilance
over paediatric medicines is to be improved by the introduction of a
European pharmacovigilance guideline specifically aimed at products for
use in children up to 18 years of age ...more
216 More counterfeit
Lipitor found in UK Counterfeit Lipitor tablets have been found in the UK for the second time
...more
216 Ending of reciprocal registration “a disaster” The decision by the Royal Pharmaceutical Society to end reciprocal arrangements with Australia has been dubbed “a disaster” by the president of the Pharmaceutical Society of Australia, Brian Grogan
...more
216 Pharmacist
jailed for fraud Defrauding the NHS of £464 has resulted in the jailing of a Yorkshire pharmacist for nine months
...more
216 NHS has potential
to make substantial savings, says AAH Huge savings could be made if the NHS updated its supply systems and adopted new business models, says Steve Dunn, group managing director of AAH Pharmaceuticals
...more
216 Phoenix takes
over EAP Phoenix Healthcare Distribution has acquired East
Anglian Pharmaceuticals ...more
217 Health trainer
early adopter sites to receive £200k Details of how
health trainers will be introduced across England were announced by public
health minister Caroline Flint in a written ministerial statement last
month ...more
217 Interviews
fail to reduce smoking in pregnancy Motivational interviewing does not reduce levels of smoking among pregnant women, a study has found
...more
217 Oral health
tackled by new pharmacy service Early identification of oral health problems is to be undertaken by community pharmacists in Fife
...more
217 Modernisation
funding for NHS announced in Scotland Funding to modernise
NHS premises in Scotland was announced this week by First Minister Jack
McConnell ...more
217 Lloyds helps
its technicians join Society’s Register An incentive
scheme encouraging pharmacy technicians to register with the Royal Pharmaceutical
Society has been launched by Lloydspharmacy ...more
|
218 Alendronate
after PTH maintains bone density Giving alendronate (Fosamax)
to postmenopausal women after a year of parathyroid hormone therapy maintains
bone mineral density, researchers have found. If parathyroid hormone
(PTH) is not followed by treatment with an antiresorptive agent improvements
in bone density are lost, they say ...more
218 BP monitoring
audit shows inaccuracy of readings Almost a fifth of sphygmomanometers
give inaccurate readings, an audit of devices in use in south London
has found ...more
218 Local policy
needed for capecitabine use in England and Wales until NICE issues advice NHS
organisations should develop their own local policy on how capecitabine
(Xeloda) is prescribed until the National Institute for Health and Clinical
Excellence has issued guidance, Andrea Sutcliffe, the deputy chief executive
of NICE, said last week ...more
218 Focus should
be on primary prevention in heart disease Public health initiatives
that support the primary prevention of coronary heart disease (CHD) avoid
four times as many deaths as initiatives targeted at patients who already
have heart disease, according to a new study ...more
218 Give eplerenone
early after acute myocardial infarction In the first month
after myocardial infarction early treatment with eplerenone (Inspra)
can reduce the risk of death by 31 per cent compared with placebo, research
shows ...more
219 Better communication
will improve medicines use Appropriate use of medicines by
elderly patients can be improved by targeting the abilities of individuals,
with better doctor-patient and doctor-doctor relationships, and better
systems for transferring information between care settings, according
to a study published on BMJ Online First last week ...more
219 Electronic
wristband matches wearer to drugs An electronic wristband
that can prevent medication errors by matching the wearer with their
medicines has been designed by Claire Dunne, an industrial design and
technology student at Brunel University, London ...more
219 DoH must
recognise oxygen supplies risk, says the NPA Demand for oxygen
services from community pharmacies over Christmas may outstrip available
supplies, the National Pharmacy Association has warned the Department
of Health ...more
219 Folate associated
with reduced risk of Alzheimer's disease Intake of at least
the recommended daily allowance of folate is associated with a 55 per
cent reduction in risk of developing Alzheimer’s disease, according
to new research ...more
219 Flu vaccine
supply Problems with the supply of this autumn's influenza
vaccines look likely after at least one manufacturer admitted that its
deliveries will be delayed ...more
|
The
Pharmaceutical Journal